Canadian Medical Hall of Fame Inductee

Stiller was Canada's major voice in organ transplantation during the 1970s, 80s and early 90s. During this time, the field changed form a risky experimental undertaking to a reliable and successful venture. Stiller lead a multi-centre trial of the drug cyclosporine—an immunosuppressant that combats tissue rejection—that laid the foundation for Canada to be a world leader in transplantation. He also conducted ground-breaking research to use the drug to halt type 1 diabetes, demonstrating it was an immune disorder.

He co-founded the Robarts Research Institute, The Canadian Medical Hall of Fame, the MaRS Discovery District in Toronto, the Ontario Institute for Cancer Research, the Canadian Medical Discoveries Fund and the Stiller Centre.

Stiller was named one of the university's 100 Alumni of Influence during the U of S centennial in 2007 and has received numerous other awards and accolades throughout his successful career.

Official induction will take place in April 2010, in Calgary, AB.

This marks the second straight year that an U of S alumnus has been inducted to the Canadian Medical Association Hall of Fame; Dr. Sylvia Fedoruk (BA '49, MA 51, LLD '06) was inducted in 2009.

For more information on the Canadian Medical Hall of Fame and its members, visit www.cdnmedhall.org.